Impaired arachidonic acid-mediated activation of large-conductance Ca 2+-activated K+ channels in coronary arterial smooth muscle cells in Zucker Diabetic Fatty rats

Diabetes

Volumn 54, Issue 7, 2005, Pages 2155-2163

  Lu, Tong ^a   Wang, Xiao Li ^a   He, Tongrong ^a   Zhou, Wei ^a   Kaduce, Terry L ^b   Katusic, Zvonimir S ^a   Spector, Arthur A ^b   Lee, Hon Chi ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ARACHIDONIC ACID; BAICALEIN; CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM ION; COMPLEMENTARY DNA; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ILOPROST; INDOMETACIN; MESSENGER RNA; PROADIFEN; PROSTACYCLIN; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARACHIDONIC ACID METABOLISM; ARTERY DILATATION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ENZYME ACTIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; RAT STRAIN; REAL TIME POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ANIMALS; ARACHIDONIC ACID; BASE SEQUENCE; CORONARY VESSELS; DIABETES MELLITUS, TYPE 2; DNA PRIMERS; GENE EXPRESSION REGULATION; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MUSCLE, SMOOTH, VASCULAR; OBESITY; POLYMERASE CHAIN REACTION; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; RATS; RATS, ZUCKER;

EID: 21344451385     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.54.7.2155     Document Type: Article

References (44)

1. Beckman JA, Creager MA, Libby P: Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287:2570-2581, 2002
2. Cooper ME, Bonnet F, Oldfield M, Jandeleit-Dahm K: Mechanisms of diabetic vasculopathy: an overview. Am J Hypertens 14:475-486, 2001
3. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM: Endothelial dysfunction in diabetes. Br J Pharmacol 130:963-974, 2000
4. Li PL, Campbell WB: Epoxyeicosatrienoic acids activate K+ channels in coronary smooth muscle through a guanine nucleotide binding protein. Circ Res 80:877-884, 1997
5. Lu T, Katakam PV, VanRollins M, Weintraub NL, Spector AA, Lee HC: Dihydroxyeicosatrienoic acids are potent activators of Ca(2+)-activated K(+) channels in isolated rat coronary arterial myocytes. J Physiol 534:651-667, 2001
6. Zink MH, Oltman CL, Lu T, Katakam PV, Kaduce TL, Lee H, Dellsperger KC, Spector AA, Myers PR, Weintraub NL: 12-lipoxygenase in porcine coronary microcirculation: implications for coronary vasoregulation. Am J Physiol Heart Circ Physiol 280:H693-H704, 2001
7. Brash AR: Arachidonic acid as a bioactive molecule. J Clin Invest 107:1339-1345, 2001
8. Vila L: Cyclooxygenase and 5-lipoxygenase pathways in the vessel wall: role in atherosclerosis. Med Res Rev 24:399-424, 2004
9. Schildknecht S, Bachschmid M, Baumann A, Ullrich V: COX-2 inhibitors selectively block prostacyclin synthesis in endotoxin-exposed vascular smooth muscle cells. FASEB J 18:757-759, 2004
10. Debey S, Meyer-Kirchrath J, Schror K: Regulation of cyclooxygenase-2 expression by iloprost in human vascular smooth muscle cells: role of transcription factors CREB and ICER. Biochem Pharmacol 65:979-988, 2003
11. Taylor PD: The effect of hyperglycaemia on function of rat isolated mesenteric resistance artery. Clin Sci 88:245-255, 1995
12. Migdalis IN, Kalogeropoulou K, Iliopoulou V, Triantafilou P, Charalabides J, Mortzos G, Cordopatis C: Plasma levels of endothelin, lipid peroxides and prostacyclin in diabetic patients with macroangiopathy. Diabetes Res Clin Pract 54:129-136, 2001
13. Matsumoto K, Morishita R, Tomita N, Moriguchi A, Yamasaki K, Aoki M, Nakamura T, Higaki J, Ogihara T: Impaired endothelial dysfunction in diabetes mellitus rats was restored by oral administration of prostaglandin I2 analogue. J Endocrinol 175:217-223, 2002
14. Brayden JE, Nelson MT: Regulation of arterial tone by activation of calcium-dependent potassium channels. Science 256:532-535, 1992
15. Nelson MT, Cheng H, Rubart M, Santana LF, Bonev AD, Knot HJ, Lederer WJ: Relaxation of arterial smooth muscle by calcium sparks. Science 270:633-637, 1995
16. Nelson MT, Quayle JM: Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 268:C799-C822, 1995
17. Tanaka Y, Koike K, Toro L: MaxiK channel roles in blood vessel relaxations induced by endothelium-derived relaxing factors and their molecular mechanisms. J Smooth Muscle Res 40:125-153, 2004
18. Scornik FS, Codina J, Birnbaumer L, Toro L: Modulation of coronary smooth muscle KCa channels by Gs alpha independent of phosphorylation by protein kinase A. Am J Physiol 265:H1460-H1465, 1993
19. Robertson BE, Schubert R, Hescheler J, Nelson MT: cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells. Am J Physiol 265:C299-C303, 1993
20. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA: Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368:850-853, 1994
21. Shipston MJ, Armstrong DL: Activation of protein kinase C inhibits calcium-activated potassium channels in rat pituitary tumour cells. J Physiol 493:665-672, 1996
22. Schöpf S, Bringmann A, Reichenbach A: Protein kinases A and C are opponents in modulating glial Ca2+ - activated K+ channels. Neuroreport 10:1323-1327, 1999
23. Hsu FF, Bohrer A, Wohltmann M, Ramanadham S, Ma Z, Yarasheski K, Turk J: Electrospray ionization mass spectrometric analyses of changes in tissue phospholipid molecular species during the evolution of hyperlipidemia and hyperglycemia in Zucker diabetic fatty rats. Lipids 35:839-854, 2000
24. Zhou W, Wang XL, Kaduce TL, Spector AA, Lee HC: Impaired arachidonic acid-mediated dilation of small mesenteric arteries in Zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol 288:H2210-H2218, 2005
25. He T, Weintraub NL, Goswami PC, Chatterjee P, Flaherty DM, Domann FE, Oberley LW: Redox factor-1 contributes to the regulation of progression from G0/G1 to S by PDGF in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 285:H804-H812, 2003
26. Ueno S, Yamada H, Moriyama T, Honda K, Takano Y, Kamiya HO, Katsuragi T: Measurement of dorsal root ganglion P2X mRNA by SYBR Green fluorescence. Brain Res Brain Res Protoc 10:95-101, 2002
27. Waitkus-Edwards KR, Martinez-Lemus LA, Wu X, Trzeciakowski JP, Davis MJ, Davis GE, Meininger GA: alpha(4)beta(1) Integrin activation of L-type calcium channels in vascular smooth muscle causes arteriole vasoconstriction. Circ Res 90:473-480, 2002
28. Zhu S, Han G, White RE: PGE2 action in human coronary artery smooth muscle: role of potassium channels and signaling cross-talk. J Vasc Res 39:477-488, 2002
29. Lange A, Gebremedhin D, Narayanan J, Harder D: 20-Hydroxyeicosatetraenoic acid-induced vasoconstriction and inhibition of potassium current in cerebral vascular smooth muscle is dependent on activation of protein kinase C. J Biol Chem 272:27345-27352, 1997
30. Yamaki F, Kaga M, Horinouchi T, Tanaka H, Koike K, Shigenobu K, Toro L, Tanaka Y: MaxiK channel-mediated relaxation of guinea-pig aorta following stimulation of IP receptor with beraprost via cyclic AMP-dependent and -independent mechanisms. Naunyn Schmiedebergs Arch Pharmacol 364:538-550, 2001
31. Miura H, Gutterman DD: Human coronary arteriolar dilation to arachidonic acid depends on cytochrome P-450 monooxygenase and Ca2+-activated K+ channels. Circ Res 83:501-507, 1998
32. Oilman CL, Kane NL, Miller FJ Jr, Spector AA, Weintraub NL, Dellsperger KC: Reactive oxygen species mediate arachidonic acid-induced dilation in porcine coronary microvessels. Am J Physiol Heart Circ Physiol 285: H2309-H2315, 2003
33. Miller AW, Katakam PV, Lee HC, Tulbert CD, Busija DW, Weintraub NL: Arachidonic acid-induced vasodilation of rat small mesenteric arteries is lipoxygenase-dependent. Pharmacol Exp Ther 304:139-144, 2003
34. Moncada S, Higgs EA, Vane JR: Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation. Lancet 1:18-20, 1977
35. Clarke AL, Petrou S, Walsh JV Jr, Singer JJ: Modulation of BK(Ca) channel activity by fatty acids: structural requirements and mechanism of action. Am J Physiol Cell Physiol 283:C1441-C1453, 2002
36. Wang R, Wu Y, Tang G, Wu L, Hanna ST: Altered L-type Ca(2+) channel currents in vascular smooth muscle cells from experimental diabetic rats. Am J Physiol Heart Circ Physiol 278:H714-H722, 2000
37. Wang R, Wang Z, Wu L, Hanna ST, Peterson-Wakeman R: Reduced vasorelaxant effect of carbon monoxide in diabetes and the underlying mechanisms. Diabetes 50:166-174, 2001
38. Liu Y, Terata K, Rusch NJ, Gutterman DD: High glucose impairs voltage-gated K(+) channel current in rat small coronary arteries. Circ Res 89:146-152, 2001
39. Miura H, Wachtel RE, Loberiza FR Jr, Saito T, Miura M, Nicolosi AC, Gutterman DD: Diabetes mellitus impairs vasodilation to hypoxia in human coronary arterioles: reduced activity of ATP-sensitive potassium channels. Circ Res 92:151-158, 2003
40. Dimitropoulou C, Han G, Miller AW, Molero M, Fuchs LC, White RE, Carrier GO: Potassium (BK(Ca)) currents are reduced in microvascular smooth muscle cells from insulin-resistant rats. Am J Physiol Heart Circ Physiol 282:H908-H917, 2002
41. Wise H: Multiple signalling options for prostacyclin. Acta Pharmacol Sin 24:625-630, 2003
42. 2 receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes 51:198-203, 2002
43. Cosentino F, Eto M, De Paolis P, van der Loo B, Bachschmid M, Ullrich V, Kouroedov A, Delli Gatti C, Joch H, Volpe M, Luscher TF: High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation 107:1017-1023, 2003
44. Souza JM, Choi I, Chen Q, Weisse M, Daikhin E, Yudkoff M, Obin M, Ara J, Horwitz J, Ischiropoulos H: Proteolytic degradation of tyrosine nitrated proteins. Arch Biochem Biophys 380:360-366, 2000